Simplex Trading
COGT icon

Simplex Trading’s Cogent Biosciences COGT Stock Holding History

Simplex Trading’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.36M Buy
61,100
+14,700
+32% +$514K ﹤0.01% 1853
2026
Q1 		$1.79M Sell
46,400
-26,900
-37% -$993K ﹤0.01% 1925
2025
Q4 		$2.6M Buy
73,300
+54,100
+282% +$1.52M ﹤0.01% 1766
2025
Q3 		$275K Buy
19,200
+9,900
+106% +$117K ﹤0.01% 4581
2025
Q2 		$66K Buy
9,300
+8,900
+2,225% +$49.3K ﹤0.01% 5638
2025
Q1 		$2K Sell
400
-43,300
-99% -$339K ﹤0.01% 7950
2024
Q4 		$340K Sell
43,700
-600
-1% -$5.98K ﹤0.01% 3927
2024
Q3 		$478K Sell
44,300
-23,000
-34% -$224K ﹤0.01% 3637
2024
Q2 		$567K Buy
67,300
+16,300
+32% +$124K ﹤0.01% 3535
2024
Q1 		$342K Buy
51,000
+25,300
+98% +$156K ﹤0.01% 4243
2023
Q4 		$151K Buy
25,700
+17,100
+199% +$131K ﹤0.01% 4964
2023
Q3 		$83K Buy
8,600
+7,500
+682% +$89K ﹤0.01% 5276
2023
Q2 		$13K Buy
1,100
+200
+22% +$2.29K ﹤0.01% 7148
2023
Q1 		$9K Buy
900
+200
+29% +$2.56K ﹤0.01% 7603
2022
Q4 		$8K Sell
700
-300
-30% -$3.72K ﹤0.01% 7709
2022
Q3 		$14K Sell
1,000
-64,400
-98% -$883K ﹤0.01% 7899
2022
Q2 		$589K Buy
65,400
+64,900
+12,980% +$443K ﹤0.01% 3249
2022
Q1 		$3K Buy
+500
New +$3.48K ﹤0.01% 9672

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Simplex Trading's COGT Position: Q2 2026 in Review

Simplex Trading reduced its Cogent Biosciences (COGT) stake by 91% in Q2 2026, selling an estimated $101K and leaving 277 shares worth $10.7K. The position accounts for ﹤0.01% of the portfolio, ranked #7646.

Simplex Trading first reported a position in COGT in Q4 2021 and has held it in 12 quarters since. The position peaked at $961K in Q3 2025. 324 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • Simplex Trading held 277 shares of Cogent Biosciences worth $10.7K as of Q2 2026.
  • Simplex Trading sold 2,876 Cogent Biosciences shares in Q2 2026, an estimated $101K.
  • Cogent Biosciences made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #7646 holding.
  • Simplex Trading first reported a position in Cogent Biosciences in Q4 2021 and has held it in 12 quarters since.
  • Simplex Trading's Cogent Biosciences position peaked at $961K in Q3 2025.
  • 324 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.